Decoy Therapeutics earnings were -$12.5M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest DCOY earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$9.0M, up 927.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DCOY reported annual earnings of -$12.5M, with 124.5% growth.
What were Decoy Therapeutics's earnings last quarter?
Decoy Therapeutics (NASDAQ: DCOY) reported Q4 2025 earnings per share (EPS) of $42.90, up 94.98% year over year. Total DCOY earnings for the quarter were -$8.98 million. In the same quarter last year, Decoy Therapeutics's earnings per share (EPS) was $854.46.
As of the last Decoy Therapeutics earnings report, Decoy Therapeutics is currently losing money. Decoy Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$12.52 million, a 124.52% increase year over year.
What was DCOY's earnings growth in the past year?
As of Decoy Therapeutics's earnings date in Q2 2026, Decoy Therapeutics's earnings has grown year over year. DCOY earnings in the past year totalled -$12.52 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.